Belysse's Plummeting European EBITDA Points to a More Severe Downturn Than Anticipated by the Market

Belysse’s Financial Results: A Deeper Downturn Than Expected

While the market had anticipated a challenging year, Belysse’s latest results revealed an even more severe downturn than forecasted. The company’s consolidated revenue dropped by 9.3% year-over-year to €254.2 million, marking a sharper decline than the previous year. The European division was the main drag, with sales falling 12.2%. More concerning was the significant hit to profitability: adjusted EBITDA tumbled 19.0% to €34.4 million, and the margin narrowed to 13.5% from 15.1%. This was not just a slowdown, but a notable contraction in the company’s earnings power.

The gap between expectations and reality widened, largely due to the acute weakness in Europe. Adjusted EBITDA in the region plummeted 56.8% to just €4.5 million, highlighting a major operational setback. This was not a minor blip, but a collapse in a critical profit center. Although investors had braced for a tough year, the scale of the European decline and the overall margin squeeze suggest last year’s performance was not a reliable baseline.

Overall, the results point to a more profound and structural downturn than previously anticipated.

Balance Sheet Pressures and Liquidity Concerns

Belysse’s financial position is worsening rather than stabilizing. The company’s outlook for 2026 is now more cautious, as it faces a tougher balance sheet environment. Leverage is the most immediate concern: net debt rose to €128.6 million, pushing net leverage up to 4.2x from 3.1x—a significant increase that erodes financial flexibility. For a company already facing a weak year, higher leverage means the road to recovery will be more costly and constrained.

RSI Oversold Long Strategy Backtest

• Strategy: Long-only on BLYSS; enter when RSI(14) < 30, exit when RSI(14) > 70, after 20 trading days, or if take-profit (+8%) or stop-loss (−4%) is hit. Backtest period: 2024-03-13 to 2026-03-13.
• Key Results:
  • Strategy Return: 20.66%
  • Annualized Return: 9.73%
  • Max Drawdown: 8.44%
  • Profit-Loss Ratio: 1.52
  • Total Trades: 7 (5 wins, 2 losses)
  • Win Rate: 71.43%
  • Average Hold: 13.43 days
  • Max Consecutive Losses: 2
  • Average Win: 5.28%
  • Average Loss: 3.36%
  • Best Single Trade: 8.52%
  • Worst Single Trade: 4.04%

Liquidity and Tax Signals

The company’s liquidity position is also tightening. Available liquidity dropped to €49.3 million at year-end, down from €52.7 million. While this still provides a cash cushion, the decrease reduces Belysse’s ability to handle unexpected challenges or invest in new opportunities without taking on more debt—further compounding leverage concerns.

Another warning sign comes from the tax line: Belysse reported a tax expense of €3.5 million despite a pre-tax loss of €3.1 million. This accounting outcome indicates the company is not recognizing deferred tax assets for its losses, meaning it may not be able to offset future profits with past losses. This suggests the market is anticipating a longer period of earnings pressure, not just a short-term setback.

Outlook: Financial Headwinds Remain

In summary, Belysse’s financial situation is more strained than the market may have previously reflected. Rising leverage, shrinking liquidity, and limited tax relief all point to a company with less room to maneuver through ongoing challenges. This sets the stage for a difficult 2026, where any further operational setbacks could quickly test the company’s financial resilience.

Catalysts and Risks: What Lies Ahead

Belysse’s current low valuation reflects expectations of continued deterioration. The main risk is that the European market’s weakness—which drove most of the revenue and profit decline—persists. With a 12.2% revenue drop and a dramatic 56.8% fall in adjusted EBITDA, Europe’s troubles are not minor. If this trend continues, the strain from higher leverage and reduced liquidity will only worsen, justifying the market’s pessimism.

On the other hand, the U.S. business has shown more resilience, with revenue down just 7.0% and adjusted EBITDA falling only 6.7%. The U.S. remains the main profit driver, contributing €29.9 million in adjusted EBITDA. If management can stabilize or improve this core business, it would indicate the company’s issues are not systemic and could mark the beginning of a recovery.

The next major catalyst will be management’s guidance for 2026. Investors have already priced in a weak year based on 2025 results. What matters now is whether leadership signals further deterioration or hints at stabilization. The company noted some improvement in its order book at the end of 2025. If 2026 guidance reflects this and points to margin recovery, the stock could be re-rated. However, if expectations are reset even lower, there may be little downside left. For now, the outlook is binary: the market expects failure, but a credible turnaround plan could quickly shift sentiment.